Effect of Cyclosporin A on rat thymus: time course analysis by immunoperoxidase technique and flow cytofluorometry. 1988

M Tanaka, and K Shinohara, and T Fukumoto, and H Tanaka, and T Kaneko
Third Department of Internal Medicine, Yamaguchi University School of Medicine, Ube, Japan.

The effect of Cyclosporin A (CyA) administration 20 mg/kg body weight i.p. for 3 or 7 days on rat lymphoid tissues, especially on the thymus, and the recovery after stopping CyA treatment were investigated by both immunoperoxidase technique and flow cytofluorometry using monoclonal antibodies against rat lymphocytes: OX6, OX7, OX8, OX18 and W3/25. The marked reduction of thymic medulla with CyA treatment was clearly demonstrated by staining with OX18. This change was maximal 7 to 10 days after the start of CyA administration. The obvious restitution of the thymic medulla occurred about 7 days after stopping CyA and was almost completed within 14 days. Flow-cytofluorometric analysis of the thymus showed that the percentages of positive cells labelled with OX7, OX8, OX18 and W3/25 appeared to be not changed except for OX18 during and after CyA treatment. However, the expression of each antigen per cell changed in the amount; the peak of fluorescence intensity of OX7+ cells showed a temporary shift to the right during CyA treatment. Bright positive cell populations for each OX8 and W3/25 increased relatively during CyA treatment, and reverted to the normal levels soon after stopping the CyA treatment. On the other hand, bright OX18+ cells decreased with CyA treatment, but this change recovered gradually after stopping the CyA treatment. Treatment with CyA gave no significant changes in the flow-cytofluorometric analyses for these antibodies on lymph node cells. Natural killer cell activity and the ability to cause local graft-versus-host reaction were not inhibited with CyA treatment. These results suggest that CyA inhibits the proliferation and differentiation of thymocytes, or that CyA makes thymocytes migrate rapidly from cortex to periphery.

UI MeSH Term Description Entries
D007124 Immunoenzyme Techniques Immunologic techniques based on the use of: (1) enzyme-antibody conjugates; (2) enzyme-antigen conjugates; (3) antienzyme antibody followed by its homologous enzyme; or (4) enzyme-antienzyme complexes. These are used histologically for visualizing or labeling tissue specimens. Antibody Enzyme Technique, Unlabeled,Enzyme Immunoassay,Enzyme-Labeled Antibody Technique,Immunoassay, Enzyme,Immunoperoxidase Techniques,Peroxidase-Antiperoxidase Complex Technique,Peroxidase-Labeled Antibody Technique,Antibody Enzyme Technic, Unlabeled,Enzyme-Labeled Antibody Technic,Immunoenzyme Technics,Immunoperoxidase Technics,Peroxidase-Antiperoxidase Complex Technic,Peroxidase-Labeled Antibody Technic,Antibody Technic, Enzyme-Labeled,Antibody Technic, Peroxidase-Labeled,Antibody Technics, Enzyme-Labeled,Antibody Technics, Peroxidase-Labeled,Antibody Technique, Enzyme-Labeled,Antibody Technique, Peroxidase-Labeled,Antibody Techniques, Enzyme-Labeled,Antibody Techniques, Peroxidase-Labeled,Enzyme Immunoassays,Enzyme Labeled Antibody Technic,Enzyme Labeled Antibody Technique,Enzyme-Labeled Antibody Technics,Enzyme-Labeled Antibody Techniques,Immunoassays, Enzyme,Immunoenzyme Technic,Immunoenzyme Technique,Immunoperoxidase Technic,Immunoperoxidase Technique,Peroxidase Antiperoxidase Complex Technic,Peroxidase Antiperoxidase Complex Technique,Peroxidase Labeled Antibody Technic,Peroxidase Labeled Antibody Technique,Peroxidase-Antiperoxidase Complex Technics,Peroxidase-Antiperoxidase Complex Techniques,Peroxidase-Labeled Antibody Technics,Peroxidase-Labeled Antibody Techniques,Technic, Enzyme-Labeled Antibody,Technic, Immunoenzyme,Technic, Immunoperoxidase,Technic, Peroxidase-Antiperoxidase Complex,Technic, Peroxidase-Labeled Antibody,Technics, Enzyme-Labeled Antibody,Technics, Immunoenzyme,Technics, Immunoperoxidase,Technics, Peroxidase-Antiperoxidase Complex,Technics, Peroxidase-Labeled Antibody,Technique, Enzyme-Labeled Antibody,Technique, Immunoenzyme,Technique, Immunoperoxidase,Technique, Peroxidase-Antiperoxidase Complex,Technique, Peroxidase-Labeled Antibody,Techniques, Enzyme-Labeled Antibody,Techniques, Immunoenzyme,Techniques, Immunoperoxidase,Techniques, Peroxidase-Antiperoxidase Complex,Techniques, Peroxidase-Labeled Antibody
D007694 Killer Cells, Natural Bone marrow-derived lymphocytes that possess cytotoxic properties, classically directed against transformed and virus-infected cells. Unlike T CELLS; and B CELLS; NK CELLS are not antigen specific. The cytotoxicity of natural killer cells is determined by the collective signaling of an array of inhibitory and stimulatory CELL SURFACE RECEPTORS. A subset of T-LYMPHOCYTES referred to as NATURAL KILLER T CELLS shares some of the properties of this cell type. NK Cells,Natural Killer Cells,Cell, NK,Cell, Natural Killer,Cells, NK,Cells, Natural Killer,Killer Cell, Natural,NK Cell,Natural Killer Cell
D008198 Lymph Nodes They are oval or bean shaped bodies (1 - 30 mm in diameter) located along the lymphatic system. Lymph Node,Node, Lymph,Nodes, Lymph
D008297 Male Males
D009929 Organ Size The measurement of an organ in volume, mass, or heaviness. Organ Volume,Organ Weight,Size, Organ,Weight, Organ
D011919 Rats, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations or by parent x offspring matings carried out with certain restrictions. This also includes animals with a long history of closed colony breeding. August Rats,Inbred Rat Strains,Inbred Strain of Rat,Inbred Strain of Rats,Inbred Strains of Rats,Rat, Inbred Strain,August Rat,Inbred Rat Strain,Inbred Strain Rat,Inbred Strain Rats,Inbred Strains Rat,Inbred Strains Rats,Rat Inbred Strain,Rat Inbred Strains,Rat Strain, Inbred,Rat Strains, Inbred,Rat, August,Rat, Inbred Strains,Rats Inbred Strain,Rats Inbred Strains,Rats, August,Rats, Inbred Strain,Strain Rat, Inbred,Strain Rats, Inbred,Strain, Inbred Rat,Strains, Inbred Rat
D003524 Cyclosporins A group of closely related cyclic undecapeptides from the fungi Trichoderma polysporum and Cylindocarpon lucidum. They have some antineoplastic and antifungal action and significant immunosuppressive effects. Cyclosporins have been proposed as adjuvants in tissue and organ transplantation to suppress graft rejection. Cyclosporines
D005260 Female Females
D005434 Flow Cytometry Technique using an instrument system for making, processing, and displaying one or more measurements on individual cells obtained from a cell suspension. Cells are usually stained with one or more fluorescent dyes specific to cell components of interest, e.g., DNA, and fluorescence of each cell is measured as it rapidly transverses the excitation beam (laser or mercury arc lamp). Fluorescence provides a quantitative measure of various biochemical and biophysical properties of the cell, as well as a basis for cell sorting. Other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake. Cytofluorometry, Flow,Cytometry, Flow,Flow Microfluorimetry,Fluorescence-Activated Cell Sorting,Microfluorometry, Flow,Cell Sorting, Fluorescence-Activated,Cell Sortings, Fluorescence-Activated,Cytofluorometries, Flow,Cytometries, Flow,Flow Cytofluorometries,Flow Cytofluorometry,Flow Cytometries,Flow Microfluorometries,Flow Microfluorometry,Fluorescence Activated Cell Sorting,Fluorescence-Activated Cell Sortings,Microfluorimetry, Flow,Microfluorometries, Flow,Sorting, Fluorescence-Activated Cell,Sortings, Fluorescence-Activated Cell
D006087 Graft vs Host Reaction An immunological attack mounted by a graft against the host because of HISTOINCOMPATIBILITY when immunologically competent cells are transplanted to an immunologically incompetent host; the resulting clinical picture is that of GRAFT VS HOST DISEASE. HLA Sensitization,Human Leukocyte Antigen Sensitization,Sensitization, HLA

Related Publications

M Tanaka, and K Shinohara, and T Fukumoto, and H Tanaka, and T Kaneko
December 1990, Clinical and experimental immunology,
M Tanaka, and K Shinohara, and T Fukumoto, and H Tanaka, and T Kaneko
December 1974, Experimental cell research,
M Tanaka, and K Shinohara, and T Fukumoto, and H Tanaka, and T Kaneko
July 1982, Clinical and experimental immunology,
M Tanaka, and K Shinohara, and T Fukumoto, and H Tanaka, and T Kaneko
July 1978, Cell and tissue kinetics,
M Tanaka, and K Shinohara, and T Fukumoto, and H Tanaka, and T Kaneko
October 1990, The Tohoku journal of experimental medicine,
M Tanaka, and K Shinohara, and T Fukumoto, and H Tanaka, and T Kaneko
August 1995, International journal of experimental pathology,
M Tanaka, and K Shinohara, and T Fukumoto, and H Tanaka, and T Kaneko
August 1982, European journal of immunology,
M Tanaka, and K Shinohara, and T Fukumoto, and H Tanaka, and T Kaneko
January 1992, Journal of comparative pathology,
M Tanaka, and K Shinohara, and T Fukumoto, and H Tanaka, and T Kaneko
June 1988, Nihon Geka Gakkai zasshi,
M Tanaka, and K Shinohara, and T Fukumoto, and H Tanaka, and T Kaneko
April 1994, Bollettino della Societa italiana di biologia sperimentale,
Copied contents to your clipboard!